Cancer letters

Keyphrases

Publications

volume 604, 2024

Antonios N Gargalionis, Kostas A Papavassiliou, Efthimia K Basdra, Athanasios G Papavassiliou
Exploiting tumor mechanomedicine for lung cancer treatment. Cancer letters 604 (2024)

volume 603, 2024

Cheng-Jie Feng, Peng Zhao, Hai-Xia Fu, Chen-Hua Yan, Chen-Cong Wang, Xiao-Lu Zhu, Yun He, Feng-Rong Wang, Yuan-Yuan Zhang, Xiao-Dong Mo, Yuan Kong, Wei Han, Jing-Zhi Wang, Yu Wang, Huan Chen, Yu-Hong Chen, Xiang-Yu Zhao, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantation. Cancer letters 603 (2024)

volume 602, 2024

Leqi Zhou, Rongbo Wen, Chenguang Bai, Zhixuan Li, Kuo Zheng, Yue Yu, Tianshuai Zhang, Hang Jia, Zhiyin Peng, Xiaoming Zhu, Zheng Lou, Liqiang Hao, Guanyu Yu, Fu Yang, Wei Zhang
Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis. Cancer letters 602 (2024)
Huan Wu, Chenggong Sun, Wenyu Cao, Qiuli Teng, Xinyue Ma, Helgi B Schiöth, Ruifen Dong, Qing Zhang, Beihua Kong
Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer. Cancer letters 602 (2024)
Yizhe Liu, Qili Shi, Yanfang Liu, Xinrong Li, Zhen Wang, Shenglin Huang, Zhiao Chen, Xianghuo He
Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer. Cancer letters 602 (2024)
Jiajia Zeng, Long Zhang, Linying Huang, Xinyuan Yu, Linyu Han, Yanxiu Zheng, Teng Wang, Nasha Zhang, Ming Yang
MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation. Cancer letters 602 (2024)

volume 601, 2024

Jun Wu, Yong Chen, Hui Zou, Kaiyue Xu, Jiaqi Hou, Mengmeng Wang, Shuyu Tian, Mingjun Gao, Qinglin Ren, Chao Sun, Shichun Lu, Qiang Wang, Yusheng Shu, Shouyu Wang, Xiaolin Wang
6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. Cancer letters 601 (2024)
Wenhao Ouyang, Zhenjun Huang, Keyu Wan, Tiantian Nie, Haizhu Chen, Herui Yao
RNA ac 4 C modification in cancer: Unraveling multifaceted roles and promising therapeutic horizons. Cancer letters 601 (2024)
Xiaoxiao Wang, Limin Zhang, Le Cheng, Yufei Wang, Mengnan Li, Jiahui Yu, Zhaowu Ma, Paul Chi-Lui Ho, Gautam Sethi, Xiaoguang Chen, Lingzhi Wang, Boon-Cher Goh
Extracellular vesicle-derived biomarkers in prostate cancer care: Opportunities and challenges. Cancer letters 601 (2024)
Deng Liu, Luofu Wang, Yanli Guo
Advances in and prospects of immunotherapy for prostate cancer. Cancer letters 601 (2024)
Jiangdong Qiu, Yifan Fu, Tao Liu, Jun Wang, Yueze Liu, Zeyu Zhang, Ziwen Ye, Zhe Cao, Dan Su, Wenhao Luo, Jinxin Tao, Guihu Weng, Liyuan Ye, Feifan Zhang, Zhiyong Liang, Taiping Zhang
Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion. Cancer letters 601 (2024)
Yanze Li, Ruizhi Zhang, Chengbo Fu, Qi Jiang, Peng Zhang, Yong Zhang, Jingchao Chen, Kaixiong Tao, Wei-Hua Chen, Xiangyu Zeng
Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor. Cancer letters 601 (2024)
Lei Huang, Jiaxin Wang, Xinyi Wang, Sicong Zheng, Kailin Liang, Yea Eun Kang, Jae Won Chang, Bon Seok Koo, Lihua Liu, Annamaria Gal, Yujuan Shan
Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation. Cancer letters 601 (2024)
Rexiati Ruze, Yuan Chen, Jianlu Song, Ruiyuan Xu, Xinpeng Yin, Qiang Xu, Chengcheng Wang, Yupei Zhao
Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma. Cancer letters 601 (2024)
Bo Pang, Songyuan An, Yun Liu, Tao Jiang, Wenqing Jia, Ruichao Chai, Yongzhi Wang
Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management. Cancer letters 601 (2024)
Yunfan Lin, Jiarong Zheng, Zizhao Mai, Pei Lin, Ye Lu, Li Cui, Xinyuan Zhao
Unveiling the veil of RNA binding protein phase separation in cancer biology and therapy. Cancer letters 601 (2024)
Jue Wang, Wenhao Bi, Renguang Lv, Zekun Wang, Qian Xin, Kailin Li, Yuan Chen, Qiji Liu, Xiang Zhang
SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway. Cancer letters 601 (2024)
Lin Cui, Xiaohui Xu, Hui Fan, Xinyan Wan, Qian Chen, Junhui Zhang, Chuntao Tao, Zheng Du, Yitao Wang, Jian Zhang, Jun Zeng, Ying Zhang, Chundong Zhang, Longhao Li, Youquan Bu, Yunlong Lei
Reuterin promotes pyroptosis in hepatocellular cancer cells through mtDNA-mediated STING activation and caspase 8 expression. Cancer letters 601 (2024)
Yicun Han, Yunzhou Pu, Xiaodie Liu, Zhiyi Liu, Yongqi Chen, Lei Tang, Jing Zhou, Qing Song, Qing Ji
YTHDF1 regulates GID8-mediated glutamine metabolism to promote colorectal cancer progression in m6A-dependent manner. Cancer letters 601 (2024)
Hui Huang, Gang Zhao, Tierun Wang, Yi You, Tian Zhang, Xi Chen, Jie Dong, Lei Gong, Xiaobin Shang, Fuliang Cao, Peng Tang, Hongjing Jiang, Pin Wang, Qinsong Pang, Cihui Yan, Wencheng Zhang
Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies. Cancer letters 601 (2024)

volume 600, 2024

Yunkai Yang, Xinhui Hao, Jingyao Zhang, Tianyang Gao, Miaomiao Huo, Wei Liu, Ting Hu, Tianyu Ma, Baowen Yuan, Min Zhang, Xu Teng, Hefen Yu, Wei Huang, Yan Wang
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling. Cancer letters 600 (2024)
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith Clements, Jyotsna Batra
Glycolysis, the sweet appetite of the tumor microenvironment. Cancer letters 600 (2024)
Lijie Huang, Xiaoxu Liu, Qiuying Chen, Jingyu Yang, Dongdong Zhang, Yabing Zhao, Lele Xu, Zhangfu Li, Xinyuan Liu, Shujuan Shao, Dan Li, Yongmei Song, Xuefeng Liu, Qimin Zhan
TGF-β-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization. Cancer letters 600 (2024)
Tiezheng Gu, Shauna N Vasilatos, Jun Yin, Ye Qin, Lin Zhang, Nancy E Davidson, Yi Huang
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. Cancer letters 600 (2024)
Bohan Liu, Yuting Liu, Shuang Yang, Jingwen Ye, Jiajie Hu, Si Chen, Shiyi Wu, Qinqing Liu, Fen Tang, Yiwen Liu, Yiqing He, Yan Du, Guoliang Zhang, Qian Guo, Cuixia Yang
Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER + breast cancer. Cancer letters 600 (2024)
Qian Zhang, Liang Ding, Jingyi Li, Kunyu Liu, Chengwan Xia, Sheng Chen, Xiaofeng Huang, Yumei Pu, Yuxian Song, Qingang Hu, Yuxin Wang
Single-cell RNA sequencing of OSCC primary tumors and lymph nodes reveals distinct origin and phenotype of fibroblasts. Cancer letters 600 (2024)
Jie Lu, Wen Huo, Yingze Ma, Xin Wang, Jinming Yu
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges. Cancer letters 600 (2024)
Qian Zhang, Liang Ding, Jingyi Li, Kunyu Liu, Chengwan Xia, Sheng Chen, Xiaofeng Huang, Yumei Pu, Yuxian Song, Qingang Hu, Yuxin Wang
Single-cell RNA sequencing of OSCC primary tumors and lymph nodes reveals distinct origin and phenotype of fibroblasts. Cancer letters 600 (2024)
Jie Lu, Wen Huo, Yingze Ma, Xin Wang, Jinming Yu
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges. Cancer letters 600 (2024)
Bohan Liu, Yuting Liu, Shuang Yang, Jingwen Ye, Jiajie Hu, Si Chen, Shiyi Wu, Qinqing Liu, Fen Tang, Yiwen Liu, Yiqing He, Yan Du, Guoliang Zhang, Qian Guo, Cuixia Yang
Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER + breast cancer. Cancer letters 600 (2024)
Yu-Qing Wang, Yue Ren, Robert Peter Gale, Li-Ting Niu, Xiao-Jun Huang
Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells. Cancer letters 600 (2024)
Meng Lu, Xue Gong, Yu-Min Zhang, Ya-Wei Guo, Ying Zhu, Xiang-Bin Zeng, Jia-Hui Gao, Lu-Man Liu, Dan Shu, Rong Ma, Hui-Fang Liang, Ru-Yi Zhang, Yun Xu, Bi-Xiang Zhang, Yong-Jie Lu, Zhang-Yin Ming
Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy. Cancer letters 600 (2024)
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith Clements, Jyotsna Batra
Glycolysis, the sweet appetite of the tumor microenvironment. Cancer letters 600 (2024)
Yu-Qing Wang, Yue Ren, Robert Peter Gale, Li-Ting Niu, Xiao-Jun Huang
Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells. Cancer letters 600 (2024)
Tianlong Ling, Zhanghan Dai, Houming Wang, Tran Trung Kien, Rong Cui, Tachung Yu, Jianjun Chen
Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer letters 600 (2024)
Tianlong Ling, Zhanghan Dai, Houming Wang, Tran Trung Kien, Rong Cui, Tachung Yu, Jianjun Chen
Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer letters 600 (2024)
Tiezheng Gu, Shauna N Vasilatos, Jun Yin, Ye Qin, Lin Zhang, Nancy E Davidson, Yi Huang
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. Cancer letters 600 (2024)
Yunkai Yang, Xinhui Hao, Jingyao Zhang, Tianyang Gao, Miaomiao Huo, Wei Liu, Ting Hu, Tianyu Ma, Baowen Yuan, Min Zhang, Xu Teng, Hefen Yu, Wei Huang, Yan Wang
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling. Cancer letters 600 (2024)
Lijie Huang, Xiaoxu Liu, Qiuying Chen, Jingyu Yang, Dongdong Zhang, Yabing Zhao, Lele Xu, Zhangfu Li, Xinyuan Liu, Shujuan Shao, Dan Li, Yongmei Song, Xuefeng Liu, Qimin Zhan
TGF-β-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization. Cancer letters 600 (2024)
Meng Lu, Xue Gong, Yu-Min Zhang, Ya-Wei Guo, Ying Zhu, Xiang-Bin Zeng, Jia-Hui Gao, Lu-Man Liu, Dan Shu, Rong Ma, Hui-Fang Liang, Ru-Yi Zhang, Yun Xu, Bi-Xiang Zhang, Yong-Jie Lu, Zhang-Yin Ming
Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy. Cancer letters 600 (2024)

volume 599, 2024

Zhaohan Zhang, Minghui Zhao, Qian Wang, Xilin Wang, Yu Wang, Yuze Ge, Zicheng Wu, Wenjuan Wang, Lin Shan
Forkhead box protein FOXK1 disrupts the circadian rhythm to promote breast tumorigenesis in response to insulin resistance. Cancer letters 599 (2024)
Zhaohan Zhang, Minghui Zhao, Qian Wang, Xilin Wang, Yu Wang, Yuze Ge, Zicheng Wu, Wenjuan Wang, Lin Shan
Forkhead box protein FOXK1 disrupts the circadian rhythm to promote breast tumorigenesis in response to insulin resistance. Cancer letters 599 (2024)
Yuehua Li, Jun Liu, Jingxuan Huang, Chengjiang Wei, Lingling Ge, Manhon Chung, Beiyao Zhu, Zizhen Guo, Tingting Zheng, Haibo Li, Yihui Gu, Wei Wang, Qingfeng Li, Zhichao Wang
Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas. Cancer letters 599 (2024)
Zhuoyuan Li, Xinran Liu, Nan Cai, Zhijun Zhou, Huaping Huang, Qiang Wu, Lizhou Xu, Wei-Guo Zhu, Changhua Zhang, Zhewei Wei, Danyang Li
Immune checkpoint reprogramming via sequential nucleic acid delivery strategy optimizes systemic immune responses for gastrointestinal cancer immunotherapy. Cancer letters 599 (2024)
Yutao Chen, Anni Lu, Zhangli Hu, Jinyao Li, Jun Lu
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance. Cancer letters 599 (2024)
Siyi Zou, Lei Zhang, Cen Jiang, Fanlu Li, Ying Yang, Xiaxing Deng, Jiao Zhang, Hao Chen, Lingxi Jiang, Xueyan Cheng, Lisha Deng, Lin Lin, Baiyong Shen, Chenlei Wen, Qian Zhan
Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes. Cancer letters 599 (2024)
Kinga Vojnits, Zhuohang Feng, Paige Johnson, Deanna Porras, Ekta Manocha, Sean Vandersluis, Sibylle Pfammatter, Pierre Thibault, Mick Bhatia
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs. Cancer letters 599 (2024)
Yutao Chen, Anni Lu, Zhangli Hu, Jinyao Li, Jun Lu
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance. Cancer letters 599 (2024)
Yuehua Li, Jun Liu, Jingxuan Huang, Chengjiang Wei, Lingling Ge, Manhon Chung, Beiyao Zhu, Zizhen Guo, Tingting Zheng, Haibo Li, Yihui Gu, Wei Wang, Qingfeng Li, Zhichao Wang
Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas. Cancer letters 599 (2024)
Siyi Zou, Lei Zhang, Cen Jiang, Fanlu Li, Ying Yang, Xiaxing Deng, Jiao Zhang, Hao Chen, Lingxi Jiang, Xueyan Cheng, Lisha Deng, Lin Lin, Baiyong Shen, Chenlei Wen, Qian Zhan
Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes. Cancer letters 599 (2024)